The global in vitro fertilization market size reached a value of around USD 26.75 Billion in 2025. The market is expected to grow at a CAGR of 7.10% between 2026 and 2035, reaching a value of around USD 53.12 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
7.1%
Value in USD Billion
2026-2035
*this image is indicative*
In vitro fertilization (IVF) is a type of assisted reproductive technology (ART) that entails taking eggs from ovaries and fertilising them with sperm in a lab. The process involves enhancing ovulatory function, ovum extraction from the woman's ovaries, and sperm fertilization of the ovum in a laboratory liquid. IVF is one of the most popular treatments for couples who are having infertility issues.
Read more about this report - REQUEST FREE SAMPLE COPY
The Expert Market Research’s report titled “In Vitro Fertilization Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Cycle
Market Breakup by Instrument
Market Breakup by End-User
Market Breakup by Region
According to the in vitro fertilization market research, fertility clinics end-users occupied a sizable share of the market for IVF and are anticipated to experience a rapid CAGR throughout the forecast period. When a couple has fertility-related problems, specialised clinics known as fertility clinics are often their first choice for diagnosis and treatment. Fertility clinics provide couples and individuals with specialised treatment services linked to their pregnancy and reproductive difficulties. The main drivers of the growth of the fertility clinics market globally are the rising number of fertility clinics, rising awareness of fertility clinics, and decreasing fertility rates.
In addition, the demand for assisted reproductive technology (ART) treatments is increasing, which has led to a significant rise in the number of fertility clinics and ART centres. The expansion of fertility clinics is projected to be fuelled by factors including cost-effectiveness, increased accessibility of specialists, and lower risk of hospital-acquired infections (HAIs).
In the Asia Pacific region, the in vitro fertilization market is anticipated to grow at a fast rate as a result of fertility tourism, increasing prevalence of infertility, and changing regulatory environments. The prevalence of medical conditions like diabetes as well as changes in lifestyles, including the rise in stress and obesity, lack of exercise, poor eating habits, inadequate nutrition, and an increase in pollution, are contributing to the rise in incidences of infertility. With increased infertility and availability of specialised fertility clinics, more couples and individuals are seeking in vitro fertilization in the Asia Pacific.
The major factors propelling the in vitro fertilization market in Asia Pacific are rising healthcare costs, increased use of advanced reproductive technologies, and expanding public awareness of in-vitro fertilization. In addition, the region's in-vitro fertilization market is likely to be impacted by the expanding medical tourism sector.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Boston IVF, founded in 1986 and headquartered in Massachusetts in the United States, offers reproductive technologies and patient care. The company provides services in a variety of patient care sectors, including diagnosis, treatment strategies, fertility drugs, GYN surgery procedures, fertility treatment, donor eggs, surrogacy, and embryo donations. Several clinics across the world today use laboratory and embryo sciences that Boston IVF created.
Monash IVF is a specialised assisted reproductive technology (ART) and tertiary level diagnostic ultrasound company with its headquarters in Victoria, Australia. It was developed through acquisition and growth, commencing operations in 2008 with the purchase of Repromed. With a comprehensive approach to patient care, they provide a full spectrum of professional diagnostic obstetric and gynaecological ultrasonography services and reproductive therapies.
Pelargos IVF, founded in 2015 is a boutique fertility clinic with its headquarters in Athens, Greece. The company's mission is to offer fully customised therapies to every patient, and accordingly each patient is assigned a single fertility doctor to guide them throughout their fertility journey. Pelargos IVF areas of expertise include egg donation, endometriosis, PCOS, and repeated implantation failures, and the company also designs customised IVF procedures.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include Ovation Fertility, RSMC, Bloom IVF Centre, and Pacific Fertility Center, among others.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2025, the global market for in vitro fertilization attained a value of USD 26.75 Billion.
The market is projected to grow at a CAGR of 7.10% between 2026 and 2035.
The market is estimated to witness a healthy growth in the forecast period of 2026-2035 to reach USD 53.12 Billion by 2035.
The major drivers of the market include the increasing cases of male and female infertility, increasing initiatives by various governments to enhance IVF treatment, rising awareness about IVF procedures, and growing medical tourism industry.
The increased prevalence of obesity and stress, rising consumption of alcohol and cigarettes, and advancements in IVF technology are the key trends propelling the growth of the market.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The primary types of IVF in the market are conventional IVF, IVF with ICSI, and IVF with donor eggs, among others.
Particularly in women with compromised fallopian tubes, the risk of an ectopic pregnancy increases. Furthermore, high oestrogen levels brought on by stimulation IVF can raise a baby's chance of being born prematurely and with a low birth weight.
Embryos are placed in the woman's uterus three to five days following the removal and fertilization of the egg, with the doctor inserting a tiny tube (catheter) into the woman's vagina, through the cervix, and into the uterus where the embryos are deposited for implantation.
The major players in the in vitro fertilization market are Boston IVF, Monash IVF, Pelargos IVF, Ovation Fertility, RSMC, Bloom IVF Centre, and Pacific Fertility Center, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Cycle |
|
| Breakup by Instrument |
|
| Breakup by End-User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share